Moderna CEO Stéphane Bancel discusses developing combination vaccines that can create immunity for COVID, the flu, and other respiratory viruses.

Video Transcript

STÉPHANE BANCEL: We need to be ready for whatever evolution gives us. We should get the omicron-specific booster in the clinic in the coming weeks. But we also have an alpha and a beta delta booster in the clinic, and we're also going to look at combinations through combining with COVID one single dose a year. You get your COVID booster adapted to the variants every year. You get your flu booster adapted to also the strain of flu of that year, and then we will keep adding components.

There are around 10 viruses that cause hospitalization because of infecting people in their respiratory system. You know, in 2022, people should not be dying of respiratory viruses. The technology exists. We believe the world deserves single annual shots that protects you against those 10 viruses, and Moderna will not stop until we have that broad protection for people all around the world.